Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Thoracic 2Plasma cell 2Other hematologic neoplasm 2Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 2

Interventions

Blood Specimen Collection 44Radiosurgery 41Early Intervention, Educational 34Standard of Care 32Educational Status 31Exercise 30Methods 29Drug Therapy 26Radiotherapy 23Magnetic Resonance Spectroscopy 23Practice Guidelines as Topic 22Surveys and Questionnaires 21X-Rays 17Pemetrexed 17Carboplatin 16Biopsy 16Tomography, X-Ray Computed 14Thoracic Surgery, Video-Assisted 14Therapeutics 12Interviews as Topic 12Fluorodeoxyglucose F18 12Gefitinib 11Cisplatin 11Specimen Handling 10Patient Navigation 10Cryosurgery 10Anterior Temporal Lobectomy 10anlotinib 9Surgical Procedures, Operative 9Psychiatric Rehabilitation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × pegylated granulocyte colony-stimulating factor × Thoracic × Clear all
NCT04171986 2019-11-21

Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
93 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03776604 2018-12-19

PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase NA Unknown
61 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡